New Breast Cancer Drug Is Working


Pfizer

There is some great news in the fight against breast cancer. Pfizer says an early clinical trial on the drug “palbociclib” prevented breast cancer from worsening for about 20 months. The current medications available only do so for about 10 months. This doubles the life expectancy for someone with advanced breast cancer by targeting specific proteins to block tumours. Breast cancer is the most common cancer to affect women. Several other dug manufacturers are working on similar treatments.

palbociclib

 

 

 

Pin It

LINKS

SOCIAL MEDIA

Scott Fox Scott Fox Scott Fox

QUICK CONTACT